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Abstract: The contribution of hypertension to
total mortality in the United States in 1968 and 1977 is
assessed through multiple cause death rates for all
mentions of hypertension and the death certificate
prevalence of hypertension. Age-adjusted declines in
the hypertension death rates were 32.8 per cent for
non-White females, 30.4 per cent for non-White males,
30.3 per cent for White females, and 25.2 per cent for
White males. Declines for younger non-Whites were
the greatest, about 50 per cent, although their rates
were more than twice the White rates in both years.
Death certificate prevalence also declined for all four
Introduction
groups with the greatest (16.5 per cent) for non-White
males and the least (10.4 per cent) for White males,
who only showed declines at older ages. The age
trajectory of death certificate prevalence reached a
peak at ages 50-69 for non-Whites and ages 60-79 for
Whites, with lower prevalence at the most advanced
ages. Large declines in the contribution of hyperten-
sion to mortality observed in death certificate data are
particularly striking in light of the probability that any
bias would be toward better detection and reporting
over the 10 years. (Am J Public Health 1983; 73:140-
144.)
Materials and Methods
The recent decline in ischemic heart disease (IHD)
mortality has generated much interest in its possible dynam-
ics and causes.' While investigators have examined the
underlying cause mortality trends for IHD, stroke, and
hypertensive diseases, most work in the area has not had
access to the information available in multiple cause mortal-
ity data (i.e., records of all medical entries listed on death
certificates). In an earlier presentation of trends in hyperten-
sion-related mortality in North Carolina over the years 1968
to 1977, substantial gains in information resulting from
multiple cause analysis were documented.2 Much additional
information on other diseases exists as well,3 and with the
release in the near future of public use tapes for the years
1968 to 1978,3 multiple cause data will be available to answer
many specific research questions. National multiple cause
data, however, have already been acquired for the end
points of the previous study of hypertension-related mortal-
ity, 1968 and 1977. Since these years span the time of the
greatest national decline in circulatory disease mortality as
well as the beginning of a period of intense activity in
hypertension awareness and treatment programs, it was
considered important to present information on changes in
the contribution of hypertension to mortality over the dec-
ade.
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Mortality data in both 1968 and 1977 were coded to the
8th revision of the International Classification of Diseases
Adapted for use in the US (ICDA). Hypertension is repre-
sented in the coding scheme under the special category for
hypertensive disease (codes 400-404) as well as specific four-
digit codes under the broad three-digit categories for IHD
and stroke (all codes 410.0 to 414.0 and 430.0 to 438.0 with a
fourth digit of 0, as well as 412.1 and 412.2, two codes
indicating hypertension that were added after initial publica-
tion of the ICDA).4 The analyses here consider all mentions
of hypertension: if any hypertensive code appears on any
part of the death certificate as an underlying or associated
cause of death, the death is counted in the numerator of the
rate. This procedure maximizes the amount of information
on hypertension, does not require diagnostic specificity of
the underlying cause (such as IHD versus stroke), and
allows the report of hypertension even when a competing
cause takes priority as the underlying cause of death.2
The death rate for all mentions of hypertension (the
multiple cause death rate) is formed by dividing the age-race-
sex-year-specific numerator described above by the age-
race-sex-year-specific US population. Multiple cause data
tapes containing records for all deaths in the US for the two
years were supplied by the National Center for Health
Statistics. Population estimates were prepared at the Center
for Demographic Studies, Duke University, from intercensal
interpolation of US census data adjusted for sex and race
differences in under-reporting.5 Races are White and non-
White; age groups are five-year categories from 35-39 to
85+. The average US population of 1968 and 1977 is used as
the standard for direct age-adjusted rates.
The death certificate prevalence of hypertension is
formed by dividing the same age-race-sex-year-specific nu-
AJPH February 1983, Vol. 73, No. 2140
CONTRIBUTION OF HYPERTENSION TO MORTALITY
merators by the age-race-sex-year-specific total deaths. This
statistic is analogous to the case-fraction6 and to the well-
known proportionate mortality ratio (PMR), except that with
multiple cause data, the summation of cause-specific PMRs
is not bounded by unity. Death certificate prevalence is
conceptually similar to the term prevalence at death intro-
duced by Markush and Seigel,7 although they ascertained
prevalence through surveying certifiers of a small sample of
deaths. Since changes in death certificate prevalence are
affected not only by changes in the hypertension death rates
but also by changes in the total death rate, age-adjusted per
cent declines between 1968 and 1977 are given here: non-
White males 17.6, White males 15.7, non-White females
23.0, and White females 19.0.
Results
Age-specific and age-adjusted rates of death with men-
tion of hypertension for 1968 and 1977 and their per cent
change are presented in Table 1. The magnitude of the rates
as well as their absolute and proportionate declines were
greater for non-Whites than for Whites. Dramatic declines
occurred for younger non-Whites, especially females. De-
clines by age were generally more uniform for Whites, with
females showing greater declines than males at all ages under
85. It is noteworthy that in both years White male mortality
is higher than that of White females at younger ages but
crosses over (at ages 75-79 in 1968 and 80-84 in 1977) to
become lower than female mortality at the oldest ages. This
sex crossover is not observed in the comparable underlying
cause mortality rates for IHD or stroke in either of the two
years.
The well-known race difference in hypertension mortal-
ity rates is also evident in Table 1. Non-White rates at ages
35-49 were well over three times the White rates for males in
both years, and were over five times the White rates for
females. The non-White/White mortality ratio declined con-
sistently with age and was eliminated at the oldest ages for
both sexes in both years. Between 1968 and 1977, the non-
White/White ratio declined, but this reduction was consist-
ent and of large magnitude only for the younger ages, 35-49.
Age-specific and age-adjusted death certificate preva-
lence of hypertension and per cent change are given in Table
2. Death certificate prevalence is greater for non-Whites and
for females with a rank order of non-White females, non-
White males, White females, and White males in both years.
The information in Table 2 is presented graphically in
Figure 1, which clearly shows the age trajectories and period
changes for the four groups. Males show a flatter relation-
ship of prevalence to age than females. Non-White rates
peak in the late 50s to the late 60s, about 10 years earlier than
White rates, with declining prevalence for all groups at
advanced ages. Non-White females show the highest preva-
lence, with over 20 per cent of all death certificates at ages
55-69 mentioning hypertension in 1968. Non-White females
born 1913-1917 show the highest prevalence in both years.
Substantial declines in death certificate prevalence occurred
for all age-race-sex groups with the exception of younger
White males (below age 60) who essentially showed no
change.
Discussion
These results strongly suggest that there has been a
major reduction in the contribution of hypertension to mor-
tality in the US over the 10-year period 1968-1977. These
declines are particularly striking because of the extremely
widespread attention given to hypertension during this peri-
od. Results of the Veterans Administration trial showing
mortality reductions due to anti-hypertensive therapy8 9 initi-
ated a period of intense efforts to increase levels of aware-
ness, treatment, and control of hypertension in the early
1970s. The Community Hypertension Evaluation Clinic
screened more than one million persons in schools, shopping
centers, and mobile vans between 1973 and 1975,10 and
monitoring of blood pressure and treatment of hypertension
TABLE 1-Age-Specific and Age-Adjusted Death Rate (per 100,000) for all Mentions of Hypertension by Race, Sex, and Per Cent
Change, United States, 1968 and 1977
Non-White Males White Males Non-White Females White Females
Age (years) 1968 1977 Change % 1968 1977 Change % 1968 1977 Change % 1968 1977 Change %
35-39 51.9 26.2 -49.4 6.6 4.7 -28.8 48.8 21.7 -55.5 4.3 2.6 -39.1
40-44 92.9 54.5 -41.3 15.6 12.4 -20.7 92.6 45.2 -51.2 9.9 6.7 -32.1
45-49 158.1 91.2 -42.3 32.9 26.6 -19.1 147.0 76.6 -47.9 20.6 13.6 -34.2
50-54 233.9 164.6 -29.6 65.0 49.4 -24.0 228.7 141.5 -38.1 37.7 26.5 -29.5
55-59 339.8 233.1 -31.4 111.7 89.2 -20.2 332.5 197.8 -40.5 68.1 47.9 -29.8
60-64 475.8 376.8 -20.8 187.8 150.3 -20.0 479.1 314.2 -34.4 119.8 90.1 -24.8
65-69 745.5 481.4 -35.4 294.6 232.1 -21.2 767.8 450.8 -41.3 225.2 157.0 -30.3
70-74 973.8 687.7 -29.4 455.9 344.0 -24.5 868.2 693.8 -20.1 394.8 270.0 -31.6
75-79 1075.8 908.1 -15.6 654.0 501.0 -23.4 932.2 877.7 -5.8 661.0 464.9 -29.7
80-84 1288.1 864.5 -32.9 930.6 662.6 -28.8 1078.1 793.5 -26.4 997.4 695.0 -30.3
85+ 1630.8 994.2 -39.0 1333.9 879.8 -34.0 1502.5 869.1 -42.2 1530.3 1076.3 -29.7
Age-Adjusted
(35+) 405.4 282.2 -30.4 186.8 139.8 -25.2 381.7 256.4 -32.8 164.0 114.3 -30.3
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TABLE 2-Age-Specific and Age-Adjusted Death Certificate Prevalence (Per Cent) of Hypertension by Race, Sex, and Per Cent
Change, United States, 1968 and 1977
Non-White Males White Males Non-White Females White Females
Age (years) 1968 1977 Change % 1968 1977 Change % 1968 1977 Change % 1968 1977 Change %
35-39 8.3 5.7 -31.6 2.6 2.2 -15.4 11.7 8.9 -24.2 2.9 2.3 -20.0
40-44 10.3 8.2 -20.6 3.8 3.7 -0.7 15.0 1-1.6 -23.0 4.1 3.5 -14.3
45-49 12.6 9.5 -24.2 4.8 4.9 1.4 17.6 13.4 -23.8 5.4 4.4 -18.1
50-54 13.0 11.2 -13.7 5.8 5.4 -5.7 19.8 16.1 -19.0 6.6 5.5 -16.4
55-59 13.7 11.2 -18.0 6.3 6.3 0.0 21.3 16.3 -23.3 8.3 6.7 -19.7
60-64 13.6 12.1 -10.9 7.0 6.6 -5.6 20.5 17.5 -14.5 9.9 8.1 -18.0
65-69 13.7 11.9 -13.4 7.2 6.7 -7.2 20.3 18.6 -8.5 11.5 9.5 -17.4
70-74 13.3 11.1 -17.1 7.4 6.5 -11.4 19.8 17.3 -12.6 12.1 10.3 -15.1
75-79 12.4 10.5 -15.7 7.3 6.4 -12.0 17.9 16.3 -9.2 12.1 10.7 -11.6
80-84 12.0 9.4 -21.7 7.2 5.9 -17.5 15.9 14.9 -6.1 11.2 9.8 -12.5
85+ 10.8 8.6 -20.1 6.4 5.0 -21.8 13.7 11.5 -16.7 9.1 8.0 -12.1
Age-Adjusted
(35+) 12.7 10.6 -16.5 6.7 6.0 10.4 18.4 15.9 -13.6 10.1 8.7 -13.9
at mild as well as moderate levels was advocated in the news
media as well as in medical and public health journals. It
would therefore be expected that hypertension would be
more likely to be detected, defined at a lower level of blood
pressure, and more likely to be listed on death certificates in
1977 than in 1968. Thus, substantial observed declines
occurred despite the fact that any bias in definition, detec-
tion, or reporting was probably in the opposite direction.
Annual cardiovascular mortality is generally higher in
winter months and during influenza epidemics, and it has
been suggested that declines since 1968 are attributable to
lower rates of influenza and pneumonia. "I In fact, the decline
has occurred equally in summer and winter months.'2 A
possible problem remains in interpreting data presented here
because of the two years considered, 1968, but not 1977, was
an epidemic year. US multiple cause mortality data for 1969,
however, show that hypertension death rates were only
slightly lower than in 1968. Conclusions presented here
would not be substantially altered by use of 1969 data.
Furthermore, declines in hypertension rates between 1968
and 1969 were more consistent and of greater magnitude
across age-race-sex groups than declines in influenza-pneu-
monia, suggesting, in accord with a previous report,'2 that
declines in influenza-pneumonia may actually be secondary
to those for cardiovascular disease.
Care must be taken in interpreting death certificate data
on hypertension. The lack of standardization of diagnostic
procedures, differences in the background and experience of
those filling out the death certificate (e.g., the role of non-
physician certifiers), differential access of the certifier to the
medical records of the decedent, and temporal changes in
diagnostic customs make the application of death certificate
reports to specific questions hazardous. Given these prob-
lems, Markush and Seigel's report7 of a true positive rate of
over 96 per cent for death certificate mentions of hyperten-
sion is encouraging.
Declines in the multiple cause hypertension death rates
were generally comparable to declines in underlying cause
mortality for IHD and stroke over the same period. The
declines in the age-adjusted hypertension rates were greater
than declines in IHD and less than declines in stroke
mortality.
Information on the multiple cause hypertension death
rates presented here can be compared with North Carolina
rates for the same years.2 Age-specific rates in North
Carolina were consistently higher than the US rates for all
four race-sex groups. Non-White/White mortality ratios
were also greater in North Carolina, especially at younger
ages. The observation that rates were higher in North
Carolina for nearly every age-race-sex category is in accord
with reported regional differences in the prevalence and
severity of hypertension,'3 but could conceivably be ex-
plained by regional differences in the medical certification of
deaths. Non-White rates may additionally be elevated slight-
ly by the greater proportion of Blacks in this category in
North Carolina than in the US.
Another comparison of interest is that of the death
certificate prevalence of hypertension with national esti-
mates of the population prevalence. While there are no
systematic standards for death certificate diagnosis of hyper-
tension, its report means (presumably) that hypertension, in
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TABLE 3-Prevalence of Hypertension (Per Cent) Defined as Diastolic Blood Pressure Over 95 or 110 mmHg, United States, 1973-
1975*
Black Males White Males Black Females White Females
Age
(years) .95 .110 .95 .110 .95 .110 -95 -110
30-39 18.2 5.5 10.3 1.8 14.7 4.5 5.7 1.2
40-49 27.7 9.8 15.7 3.4 25.4 9.1 11.1 2.5
50-59 33.4 12.2 19.3 4.5 31.8 10.9 14.6 3.2
60-64 31.8 11.8 18.2 4.2 31.0 11.2 14.9 3.2
65+ 28.6 10.3 15.1 3.3 27.6 9.2 14.0 3.0
*From the Community Hypertension Evaluation Clinic.9
determining the terminal condition. Thus, there might be a
bias against reporting mild or medically controlled hyperten-
sion.
Table 3 gives screening results from the Community
Hypertension Evaluation Clinic screening program for dia-
stolic blood pressures of 2 95 mmHg and 2 110 mmHg. '0
Although this program did not have a defined population
base, the prevalence estimates obtained from more than one
million persons at 1171 sites correspond well with national
population surveys of hypertension.'3 Comparison with re-
sults in Table 2 shows that the death certificate prevalence of
hypertension is higher than the population prevalence of
moderate and severe hypertension (diastolic blood pressure
110 or over) but lower than the total prevalence of hyperten-
sion including "mild" hypertension (diastolic blood pressure
95 or over). Since the prevalence of a condition related to
mortality should be higher at death than in life,7 these data
suggest that the blood pressure "threshold" used to define
hypertension on death certificates may be higher than what
is currently used to define treatment eligibility. Females
have death certificate prevalences that are closer to the 2 95
mmHg blood pressure criterion than those of males. This is
consistent with the greater use of medical services and
higher levels of hypertension awareness among females.
The age trajectory of death certificate prevalence of
hypertension, with its downturn at older ages, resembles the
trajectory of mean diastolic blood pressure in the US popula-
tion'3 and the prevalence of hypertension based on diastolic
blood pressure alone (Table 3). Mean systolic blood pres-
sure, however, continues to rise in old age,'3 and isolated
systolic hypertension may be the most common form of high
blood pressure at the oldest ages in both Blacks and
Whites. 14 Thus, the downturn in death certificate prevalence
of hypertension may reflect clinical practice of defining
hypertension in terms of its diastolic component, and not a
reduction in the overall impact of blood pressure (including
systolic) on mortality.
An alternative explanation of the downturn in death
certificate prevalence of hypertension at older ages might be
made in terms of a cohort effect, although this seems
unlikely. A downturn in the age trajectory of period rates
results from a long-term secular increase in cohort rates-as
with lung cancer-so that older ages belong to lower rate
cohorts than younger ages.'5 However, hypertension mortal-
ity rates have been declining for decades,'6 a situation that
should reduce the appearance of the downturn from what
would be seen in a cohort analysis. Unfortunately, due to
changes in the ICDA and lack of multiple cause data before
1968, such an analysis is not possible.
While national data do not suggest declines in the
population prevalence of hypertension between the 1960s
and the 1970s,'3 there is much evidence that treatment and
control programs have been reaching large numbers.'7 It has
therefore been suggested that these programs have been
responsible for declines in hypertension-related mortal-
ity. 6 8 The age-race-sex pattern of the declines presented
here, however, does not fully support this hypothesis.
Recent data on the status of awareness, treatment, and
control in the US show that older, female, and White
individuals have the highest rates of treatment and especially
control of hypertension.'7 Mortality data presented here,
however, show greatest declines in hypertension-related
mortality for younger non-Whites. If medical intervention
were the sole cause of mortality changes in the population,
observed declines should have been greatest for older fe-
males, with non-White males showing the least decline. It
should be kept in mind that mortality data, unlike communi-
ty and national survey data, are not likely to be influenced by
a participant effect. While it must be assumed that treatment
is having a beneficial effect on mortality, data presented here
support the conventional public health wisdom that major
changes in population health and mortality depend more on
changes in the physical and social environment than on
individual medical care.
This paper has shown that multiple cause mortality data
on chronic disease can be an important source of information
for assessing broad patterns in public health. Multiple cause
data have not been widely available, but plans for release of
multiple cause data tapes by the National Center for Health
Statistics should facilitate their use for the investigation of a
wide range of age, race, sex, period, cohort and, regional
differences in mortality.3 Multiple cause data present a
unique opportunity for monitoring the total contribution of
conditions to mortality.
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13th International Hospital Exposition I
"Interhospital 83" the 13th international exposition for hospital professionals, will take place June
7-10, 1983 in Dusseldorf, West Germany.
More than 800 manufacturers from around the world are expected to exhibit products and
technologies for hospital administration, maintenance, and services. Categories open to exhibitors
include: medical technology, hospital supply and equipment, and hospital service facilities.
For further information on Interhospital, contact Dusseldorf Trade Shows, 500 Fifth Avenue, New
York NY 10010. Telephone 212/840-7744.
IFT 1983 Meeting on Modern Food Analysis
The Institute of Food Technologists (IFT) will hold its Annual Basic Symposium June 17-18, 1983
in New Orleans. The topic of the symposium will be "Modern Methods of Food Analysis." Following
the symposium, the IFT will hold their Annual Meeting June 19-22, 1983 at the New Orleans
Superdome.
The Annual Meeting of the IFT is expected to attract over 10,000 members and guests. New
offerings of 550 exhibit booths and over 450 technical papers and symposia will be featured at the
meeting.
For further information, contact Dan E. Weber, Director of Marketing/Administration, Institute of
Food Technologists, Suite 2120, 221 N. LaSalle Street, Chicago, IL 60601. Telephone 312/782-8424.
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